Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00608920 · ClinicalTrials.gov registry record · NA
Single Photon Emission Computed Tomography (SPECT) Lymph Node Mapping
A NA study of Adenocarcinoma of the Prostate, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 15
- Enrollment target
- 1
- Study location
NCT00608920: Completed NA study of Adenocarcinoma of the Prostate, sponsored by Washington University School of Medicine.
NCT00608920 is a NA study of Adenocarcinoma of the Prostate that has completed, run by Washington University School of Medicine. The registered enrollment target is 15 participants, below the 109-participant average among 21 other Adenocarcinoma of the Prostate trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00608920, a NA study of Adenocarcinoma of the Prostate, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine if the planning of radiation treatment of prostate cancer patient can be made more precise by comparing currently planning techniques to an imaging technique called SPECT.
Primary Outcome
Safety: The study will be feasible if no more than 80% of patients experience the following complications: infection requiring hospitalization or IV antibiotics, urinary retention requiring placement of a Foley catheter, moderate or severe allergic reaction to Tc99. Efficacy: The study will be feasible if at least 80% of patients have at least one identifiable lymph node on SPECT-LM.
Conditions Studied
Interventions
- OTHER Single Photon Emission Computed Tomography (SPECT)
Study Locations (1)
Missouri
- Washington University School of Medicine - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2007-03 |
| Est. Completion | 2009-04 |
| Phase | NA |
What the finished NCT00608920 record still lists
NCT00608920 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 109-participant average among 21 other Adenocarcinoma of the Prostate trials with a reported enrollment target (86% lower).
The record links to 1 condition, with Adenocarcinoma of the Prostate appearing as the primary indexed condition, and to 1 intervention - of which Single Photon Emission Computed Tomography (SPECT) is the first listed.
NCT00608920 reports a single indexed study location in Missouri.
Frequently Asked Questions
What is clinical trial NCT00608920 about?
NCT00608920 is a clinical study titled "Single Photon Emission Computed Tomography (SPECT) Lymph Node Mapping". The purpose of this study is to determine if the planning of radiation treatment of prostate cancer patient can be made more precise by comparing currently planning techniques to an imaging technique called SPECT.
What is the current status of trial NCT00608920?
This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2007-03. Estimated completion is 2009-04.
What conditions does trial NCT00608920 study?
This clinical trial studies the following conditions: Adenocarcinoma of the Prostate.
What interventions are being tested in trial NCT00608920?
The interventions under investigation include: Single Photon Emission Computed Tomography (SPECT) (OTHER).
Who is sponsoring clinical trial NCT00608920?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00608920 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Adenocarcinoma of the Prostate
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00608920's enrollment target sits among peer trials
15 19th of 21 higher than 2 of 21 other Adenocarcinoma of the Prostate trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Adenocarcinoma of the Prostate trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Stereotactic Body Radiation Therapy in Treating Patients With Localized High-Risk Prostate Cancer
ACTIVE NOT RECRUITING · NA
-
Low-Fat Diet and Fish Oil in Men on Active Surveillance for Prostate Cancer
ACTIVE NOT RECRUITING · NA
-
Diffusion-Weighted MRI in Staging Patients With Localized Prostate Cancer
COMPLETED · NA
-
Intraoperative Dosimetry for Prostate Brachytherapy Using Fluoroscopy and Ultrasound
COMPLETED · NA
-
Pilot Study of 18F-DCFPyL PET/CT in the Evaluation of Men With an Elevated PSA Following Radical Prostatectomy
COMPLETED · NA
-
Dose-Escalated Proton Radiation Therapy for High-Risk Prostate Cancer
ACTIVE NOT RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia